Page last updated: 2024-10-17

cytosine and Viremia

cytosine has been researched along with Viremia in 34 studies

Viremia: The presence of viruses in the blood.

Research Excerpts

ExcerptRelevanceReference
"62 mg/kg) both without and with oral probenecid in 9 transplant patients with persistent BK viremia without nephropathy in a crossover design."3.79Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection. ( Gao, Y; Momper, JD; Randhawa, PS; Schonder, KS; Shapiro, R; Venkataramanan, R; Zhao, Y, 2013)
" The frequency and severity of adverse effects, particularly nephrotoxicity, in pediatric HSCT recipients are unclear, and pharmacokinetics (PK) of cidofovir in children have not previously been reported."2.80Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients. ( Braverman, RS; Caruso Brown, AE; Cohen, MN; Giller, R; Levin, MJ; Rooney, JF; Tong, S, 2015)
"BK viremia and nephritis are increasing problems in renal transplant recipients."2.43BK virus nephritis after renal transplantation. ( Hariharan, S, 2006)
" Brincidofovir (BCV) is an orally bioavailable lipid conjugate of cidofovir, which has activity against adenoviruses."1.51Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant. ( Kinsey, S; Meena, JP; Phillips, RS, 2019)
"BK viremia was directly correlated to HC severity (P=0."1.40High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation. ( Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X, 2014)

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (8.82)18.2507
2000's12 (35.29)29.6817
2010's17 (50.00)24.3611
2020's2 (5.88)2.80

Authors

AuthorsStudies
Hill, JA1
Nichols, WG1
Marty, FM1
Papanicolaou, GA2
Brundage, TM1
Lanier, R1
Zerr, DM1
Boeckh, MJ1
Ljungman, P2
Detweiler, CJ1
Mueller, SB1
Sung, AD1
Saullo, JL1
Prasad, VK1
Cardona, DM1
Meena, JP1
Phillips, RS1
Kinsey, S1
Qasim, W1
Gilmour, K1
Zhan, H1
Derniame, S1
McNicol, AM1
Ip, W1
Hiwarkar, P1
Veys, P1
Gaspar, HB1
Knight, RJ2
Gaber, LW2
Patel, SJ2
DeVos, JM2
Moore, LW1
Gaber, AO2
Gilis, L1
Morisset, S1
Billaud, G1
Ducastelle-Leprêtre, S1
Labussière-Wallet, H1
Nicolini, FE1
Barraco, F1
Detrait, M1
Thomas, X1
Tedone, N1
Sobh, M1
Chidiac, C1
Ferry, T1
Salles, G1
Michallet, M1
Ader, F1
Lachiewicz, AM1
Cianciolo, R1
Miller, MB1
Derebail, VK1
Kuten, SA1
Lugthart, G1
Oomen, MA1
Jol-van der Zijde, CM1
Ball, LM1
Bresters, D1
Kollen, WJ1
Smiers, FJ1
Vermont, CL1
Bredius, RG1
Schilham, MW1
van Tol, MJ1
Lankester, AC1
Lee, YJ1
Young, JW1
Seshan, SV1
Boruchov, AM1
Chittick, G1
Momméja-Marin, H1
Glezerman, IG1
Caruso Brown, AE1
Cohen, MN1
Tong, S1
Braverman, RS1
Rooney, JF1
Giller, R1
Levin, MJ1
Mohamed, M1
Parajuli, S1
Muth, B1
Astor, BC1
Panzer, SE1
Mandelbrot, D1
Zhong, W1
Djamali, A1
Patel, S1
Slatter, M1
Valappil, M1
Waugh, S1
Johnston, O1
Jaswal, D1
Gill, JS1
Doucette, S1
Fergusson, DA1
Knoll, GA1
Omar, H1
Yun, Z1
Lewensohn-Fuchs, I1
Pérez-Bercoff, L1
Orvell, C1
Engström, L1
Vuong, GK1
Keddis, M1
Leung, N1
Herrmann, S1
El-Zoghby, Z1
Sethi, S1
Momper, JD1
Zhao, Y1
Shapiro, R1
Schonder, KS1
Gao, Y1
Randhawa, PS1
Venkataramanan, R1
Cesaro, S1
Pillon, M1
Tridello, G1
Aljurf, M1
Martino, R1
Schroyens, W1
Nozzoli, C1
Barba, P1
Faraci, M1
Fagioli, F1
Cappelli, B1
Cordonnier, C1
Al-Mohareb, F1
Floisand, Y1
Greil, J1
Panizzolo, IS1
Santarone, S1
Smee, DF2
Wong, MH1
Bailey, KW2
Beadle, JR1
Hostetler, KY1
Sidwell, RW2
Ishida, H1
Shin-Nakai, N1
Yoshihara, T1
Teramura, T1
Imamura, T1
Mukouyama, A1
Morimoto, A1
Imashuku, S1
Verucchi, G1
Calza, L1
Trevisani, F1
Zambruni, A1
Tadolini, M1
Giuliani, R1
Manfredi, R1
Andreone, P1
Chiodo, F1
Bernardi, M1
Hariharan, S1
Steiner, I1
Aebi, C1
Ridolfi Lüthy, A1
Wagner, B1
Leibundgut, K1
Adams, MM1
Rice, AD1
Moyer, RW1
Mattner, F1
Sykora, KW1
Meissner, B1
Heim, A1
Jabs, DA1
Enger, C1
Dunn, JP1
Forman, M1
Hubbard, L1
Torres, G1
Kiehl, MG1
Basara, N1
Castagnola, E1
Miano, M1
Morreale, G1
Cristina, E1
Chierici, M1
Lanino, E1
Mazzi, R1
Parisi, SG1
Sarmati, L1
Uccella, I1
Nicastri, E1
Carolo, G1
Gatti, F1
Concia, E1
Andreoni, M1
Chakrabarti, S1
Collingham, KE1
Osman, H1
Fegan, CD1
Milligan, DW1
Soike, KF1
Huang, JL1
Zhang, JY1
Bohm, R1
Hitchcock, MJ1
Martin, JC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study[NCT02758288]0 participants (Actual)Observational2015-09-30Withdrawn
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for cytosine and Viremia

ArticleYear
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.
    Transplantation, 2010, May-15, Volume: 89, Issue:9

    Topics: Antiviral Agents; BK Virus; Cidofovir; Cohort Studies; Creatinine; Cytosine; Follow-Up Studies; Huma

2010
Invasive adenoviral infection in a recipient of unrelated bone marrow transplantation: Problems with diagnostic PCR.
    Pediatric blood & cancer, 2005, Volume: 44, Issue:4

    Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Cidofovir; Cytosine; Diagnostic Errors;

2005
BK virus nephritis after renal transplantation.
    Kidney international, 2006, Volume: 69, Issue:4

    Topics: Antibodies, Viral; Antiviral Agents; BK Virus; Cidofovir; Cytosine; DNA, Viral; Graft Survival; Huma

2006

Trials

5 trials available for cytosine and Viremia

ArticleYear
Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation.
    British journal of haematology, 2013, Volume: 161, Issue:3

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Antigens, Viral; Antiviral Agents; Ca

2013
Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7

    Topics: Acute Kidney Injury; Adenovirus Infections, Human; Adolescent; Antiviral Agents; BK Virus; Child; Ch

2015
Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation.
    Bone marrow transplantation, 2013, Volume: 48, Issue:6

    Topics: Adolescent; Adult; Allografts; Antiviral Agents; BK Virus; Child, Preschool; Cidofovir; Cystitis; Cy

2013
Opportunistic infection highlights from the 35th ICAAC.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:10

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocy

1995
Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance,

2001

Other Studies

26 other studies available for cytosine and Viremia

ArticleYear
Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
    Blood, 2020, 04-23, Volume: 135, Issue:17

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Cohort Studies; Cytosine; DNA, Vira

2020
Is antiviral therapy against HHV-6B beneficial?
    Blood, 2020, 04-23, Volume: 135, Issue:17

    Topics: Antiviral Agents; Cytosine; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; I

2020
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD.
    Journal of pediatric hematology/oncology, 2018, Volume: 40, Issue:6

    Topics: Adenoviridae; Adenoviridae Infections; Autografts; Child, Preschool; Colon; Cytosine; Graft vs Host

2018
Brincidofovir as a Salvage Therapy in Controlling Adenoviremia in Pediatric Recipients of Hematopoietic Stem Cell Transplant.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:7

    Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytosine; Femal

2019
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
    Transplantation, 2013, Apr-15, Volume: 95, Issue:7

    Topics: Adult; Antiviral Agents; Biopsy; BK Virus; Cidofovir; Cytosine; Early Diagnosis; Female; Glomerular

2013
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2014, Volume: 49, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs

2014
Adenovirus causing fever, upper respiratory infection, and allograft nephritis complicated by persistent asymptomatic viremia.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:4

    Topics: Adenoviridae; Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Com

2014
Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:6

    Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Female; Hu

2014
The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2

    Topics: Adenovirus Infections, Human; Adenoviruses, Human; Adolescent; Antiviral Agents; Child; Child, Presc

2015
Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 65, Issue:5

    Topics: BK Virus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Imm

2015
In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:3

    Topics: Adult; Antiviral Agents; BK Virus; Cidofovir; Creatinine; Cytosine; Female; Graft Rejection; Humans;

2016
Persistent adenoviraemia in an infant following haematopoietic stem cell transplantation.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 47, Issue:1

    Topics: Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cidofovir; Cytosine; Feces; Female; Hematop

2010
Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:5

    Topics: Adenoviridae Infections; Adult; Antiviral Agents; Asymptomatic Infections; Child; Child, Preschool;

2010
Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012, Volume: 59, Issue:6

    Topics: Acute Kidney Injury; Adenoviridae Infections; Adult; Antineoplastic Combined Chemotherapy Protocols;

2012
Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:1

    Topics: Adjuvants, Pharmaceutic; Adult; Aged; Antiviral Agents; Area Under Curve; BK Virus; Cidofovir; Cross

2013
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:5

    Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; He

2004
Human herpesvirus-8-related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin.
    Transplant infectious disease : an official journal of the Transplantation Society, 2005, Volume: 7, Issue:1

    Topics: Antibiotics, Antineoplastic; Antiviral Agents; Cidofovir; Cytosine; Daunorubicin; Drug Therapy, Comb

2005
Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adenovirus Infections, Human; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Aspa

2008
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox.
    Journal of virology, 2007, Volume: 81, Issue:20

    Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Humans; Organophosphonates;

2007
An adenovirus type F41 outbreak in a pediatric bone marrow transplant unit: analysis of clinical impact and preventive strategies.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:5

    Topics: Adenoviridae; Adenoviridae Infections; Adolescent; Antiviral Agents; Blood; Bone Marrow Transplantat

2008
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
    American journal of ophthalmology, 1998, Volume: 126, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomeg

1998
Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
    Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1

    Topics: Administration, Intranasal; Animals; Antiviral Agents; Cidofovir; Cowpox virus; Cytosine; Disease Mo

2001
Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytomegalovirus; C

2001
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS.
    AIDS (London, England), 2001, Oct-19, Volume: 15, Issue:15

    Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Disease Progression; D

2001
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytos

2001
Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys.
    Antiviral research, 1991, Volume: 16, Issue:1

    Topics: Administration, Oral; Animals; Antibodies, Viral; Antiviral Agents; Chickenpox; Chlorocebus aethiops

1991